Fas-Fas ligand interactions play a major role in effector functions of cytotoxic T lymphocytes after adenovirus vector-mediated gene transfer

Human Gene Therapy

Volumn 10, Issue 2, 1999, Pages 259-269

  Chirmule, Narendra ^a   Moscioni, A David ^a   Qian, Yinkang ^a   Qian, Ruzheng ^a   Chen, Youhai ^a   Wilson, James M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CD4 ANTIGEN; CD8 ANTIGEN; FAS LIGAND; IMMUNOGLOBULIN G ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PRIMER DNA;

ADENOVIRUS; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; IMMUNOCOMPETENCE; LACTOSE OPERON; LIGAND BINDING; LIVER CELL; MOUSE; NONHUMAN; TRANSGENE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD95; FAS LIGAND PROTEIN; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; IMMUNOPHENOTYPING; LIVER; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, CYTOTOXIC; TRANSGENES;

EID: 0033585473     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950019048     Document Type: Article

References (26)

1. CRISPE, I.N., and MEHAL, W.Z. (1996). Strange brew: T cells in the liver. Immunol. Today 17, 522-525.
2. CRYSTAL, R. (1995). Transfer of genes to humans: Early lessons and obstacles to success. Science 270, 404-410.
3. ELKON, K.B., LIU, C.-C., GALL, J.G., TREVEJO, J., MARINO, M.W., ABRAHAMSEN, K.A., SONG, X., ZHOU, J.-L., OLD, L.J., CRYSTAL, R.G., and FALCK-PEDERSEN, E. (1997). Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenovirus vectors. Proc. Natl. Acad. Sci. U.S.A. 94, 9814-9819.
4. EMOTO, M., EMOTO, Y., and KAUFMANN, S.H.E. (1997). TCR-mediated target cell lysis by CD4+ NK1+ liver T lymphocytes. Int. Immunol. 9(4), 563-571.
5. GEORGE, J.F., SWEENEY, S.D., KIRKLIN, J.K., SIMPSON, E.M., GOLDSTEIN, D.R., and THOMAS, J.M. (1998). An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow. Nature Med. 4(3), 333-335.
6. GIORDANO, C., STASSI, G., DE MARJA, R., TODARO, M., RICHIUSA, P., PAPOFF, G., RUBERTI, G., BAGNASCO, M., TESTI, R., and GALLUZZO, A. (1997). Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275(5302), 960-963.
7. GREEN, D.R., and WARE, C.F. (1997). Fas-ligand: Privilege and peril. Proc. Natl. Acad. Sci. U.S.A. 94, 5986-5990.
8. GRIFFITH, T.S., and FERGUSON, T.A. (1997). The role of FasL-induced apoptosis in immune privilege. Immunol. Today 18(5), 240-244.
9. HIRATA, H., TAKAHASHI, A., KOBAYASHI, S., YONEHARA, S., SAWAI, H., OKAZAKI, T., YAMAMOTO, K., and SASADA, M. (1998). Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J. Exp. Med. 187(4), 587-600.
10. HUANG, L., SOLDEVILA, G., LEEKER, M., FLAVELL, R., and CRISPE, I.N. (1994). The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity 1, 741-749.
11. KAGI, D., LEDERMANN, B., BURKI, K., ZINKERNAGEL, R.M., and HENGARTNER, H. (1996). Molecular mechanisms of mymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14, 207-232.
12. KATAOKA, T., TAKAKU, K., MAGAE, J., SHINOHARA, N., TAKAYAMA, H., KONDO, S., and NAGAI, K. (1994). Acidification is essential for maintaining the structure and function of lytic granules of CTL. J. Immunol. 153(9), 3938-3947.
13. KNODELL, R.G., ISHAK, K.G., BLACK, W.C., CHEN, T.S., CRAIG, R., KAPLOWITZ, N., KIERNAN, T.W., and WOLLMAN, J. (1981). Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic hepatitis. Hepatology 1, 431-435.
14. KONDO, T., SUDA, T., FUKUYAMA, H., ADACHI, M., and NAGATA, S. (1997). Essential roles of the Fas ligand in the development of hepatitis. Nature Med. 3(4), 409-413.
15. LIEBER, A., HE, C.-Y., MEUSE, L., SCHOWALTER, D., KIRILLOVA, I., WINTHER, B., and KAY, M.A. (1997). The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. J. Virol. 71, 8798-8807.
16. LIN, T., BRUNNER, T., TIETZ, B., MADSEN, J., BONFOCO, E., REAVES, M., HUFLEJT, M., and GREEN, D.R. (1998). Fas ligand-mediated killing by intestinal intraepithelial lymphocytes. J. Clin. Invest. 101(3), 570-577.
17. NAGATA, S. (1997). Apoptosis by death factor. Cell 88, 355-365.
18. OGASAWARA, J., WATANABE-FUKUNAGA, R., ADACHI, M., MATSUZAWA, A., KASUGAI, T., KITAMURA, Y., ITOH, N., SUDA, T., and NAGATA, S. (1993). Lethal effect of the anti-Fas antibody in mice. Nature (London) 364(6440), 806-809.
19. SCHOWALTER, D.B., TUBB, J.C., LIU, M., WILSON, C.B., and KAY, M.A. (1997). Heterologous expression of adenovirus E3-gp19K in an Ela-deleted adenovirus vector inhibits MHC I expression in vitro, but does not prolong transgene expression in vivo. Gene Ther. 4, 351-360.
20. SMYTH, M.J., and TRAPANI, J.A. (1998). The relative role of lymphocyte granule exocytosis versus death receptor-mediated cytotoxicity in viral pathophysiology. J. Virol. 72(1), 1-9.
21. TAKAHASHI, T., MASATO, T., BRANNAN, C.I., JENKINS, N.A., COPELAND, N.G., SUDA, T., and NAGATA, S. (1994). Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976.
22. WATANABE-FUKUNAGA, R., BRANNAN, C.I., COPELAND, N.G., JENKINS, N.A., and NAGATA, S. (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (London) 356(6367), 314-317.
23. WOLFF, G., WORGALL, S., VAN ROOIJEN, N., SONG, W.-R., HARVEY, B.-G., and CRYSTAL, R.G. (1997). Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ. J. Virol. 71, 624-629.
24. YANG, Y., ERTL, H., and WILSON, J. (1994). MHC class 1 restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1 deleted recombinant adenoviruses. Immunity 1, 433-442.
25. YANG, Y., JOOSS, K.U., SU, Q., ERTL, H.C.J., and WILSON, J.M. (1995a). Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther. 3, 137-144.
26. YANG, Y., XIANG, Z., ERTL, H.C.J., and WILSON, J.M. (1995b). Upregulation of class I MHC antigens by interferon-γ is necessary for the T cell-mediated elimination of recombinant adenovirus infected hepatocytes in vivo. Proc. Natl. Acad. Sci. U.S.A. 92, 7257-7261.